3558 results for «208»
3558 results
DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT
21 May 2025 – From EuroPCR 2025
Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.
Multi-modality assessment of coronary disease
21 May 2025 – From EuroPCR 2025
This session offers comprehensive multi-modality assessment of coronary disease, integrating advanced imaging and functional testing. Topics include diagnostic yield of OCT and cardiac MRI for MINOCA, transitioning coronary plaque vulnerability assessment from invasive to non-invasive methods, relationships between QFR and IVUS post-PCI in complex lesions, combined...
ACS with normal coronary arteries: angiography done, job done?
21 May 2025 – From EuroPCR 2025
Understand the clinical significance of MINOCA and learn diagnostic strategies integrating invasive and non-invasive tests to identify underlying etiologies. This session provides therapeutic insights tailored to specific MINOCA endotypes through illustrative cases.
New tools for left main treatment
21 May 2025 – From EuroPCR 2025
Examine new tools and strategies tailored for left main coronary artery treatment. This session covers real-world data on intracoronary imaging guidance, post-PCI FFR assessment following provisional T stenting, safety and efficacy of intravascular lithotripsy for calcified left main disease, drug-coated balloon (DCB) treatments for true bifurcation...
Optimising CTO outcomes by lesion selection
21 May 2025 – From EuroPCR 2025
Optimize chronic total occlusion (CTO) PCI outcomes through lesion selection strategies. This session reviews coronary calcium patterns via CT, target vessel considerations, distal vessel remodeling, imaging-guided versus conventional approaches, and complex lesion cases.
TAVI: contemporary practice
21 May 2025 – From EuroPCR 2025
Stay updated on contemporary TAVI practices with insights from the 2024 European TAVI PATHWAY Registry. This session addresses comprehensive risk stratification in moderate aortic stenosis, safety and efficacy of repeat TAVI procedures, comparative outcomes of explant versus redo-TAVI after valve failure, and long-term neurological outcomes following...
Hotline TAVI 2: outcomes with new and established devices
21 May 2025 – From EuroPCR 2025
Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.
Intracoronary imaging for complex PCI: a must!
21 May 2025 – From EuroPCR 2025
Recognize the indispensable role of intracoronary imaging in managing complex PCI cases. This session explores the evolution of multivessel NSTEMI treatment using DES, BRS, DCB, and imaging, challenges with recurrent in-stent restenosis across multiple stent layers, innovative imaging solutions for complex lesions, and diagnostic approaches to...
Management of stent-related complications
21 May 2025 – From EuroPCR 2025
This session addresses the management of stent-related complications through a series of dramatic clinical cases. Learn methodical approaches to routine and crisis scenarios including primary PCI complications, failure to stent, and unexpected challenges encountered during interventions, highlighting practical bailout techniques and decision-making frameworks.
How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?
21 May 2025 – From EuroPCR 2025
Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.
DCB in de novo lesions: new valid option?
20 May 2025 – From EuroPCR 2025
Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.
Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice
21 May 2025 – From EuroPCR 2025
This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...
Clinical outcomes of left main PCI
21 May 2025 – From EuroPCR 2025
This session reviews clinical outcomes of left main PCI in various contexts including ACS, complex lesion risk stratification with BCIS-CHIP score, and spontaneous coronary artery dissection. It also compares double-stent techniques and examines five-year results to guide clinical decision-making.
Complicated subendothelial dissection during left anterior descending coronary artery – first diagonal branch bifurcation treatment with Culotte technique
06 Jan 2025
Learn more about troubleshooting and tailor-made treatment combining 2D and 3D OCT thanks to this image in cardiology!
ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock
27 Aug 2023
Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.
Author
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial
26 Oct 2023
Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.
Author
ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention
29 Aug 2023
Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...
Author
Author
